83 FR 35490 - Charter Renewal for the Advisory Commission on Childhood Vaccines

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 144 (July 26, 2018)

Page Range		35490-35490
FR Document		2018-15994

HHS is hereby giving notice that the Advisory Commission on Childhood Vaccines (ACCV) has been rechartered. The effective date of the renewed charter is July 20, 2018.

Federal Register, Volume 83 Issue 144 (Thursday, July 26, 2018)

[Federal Register Volume 83, Number 144 (Thursday, July 26, 2018)]
[Notices]
[Page 35490]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-15994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Charter Renewal for the Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice of charter renewal.

-----------------------------------------------------------------------

SUMMARY: HHS is hereby giving notice that the Advisory Commission on 
Childhood Vaccines (ACCV) has been rechartered. The effective date of 
the renewed charter is July 20, 2018.

FOR FURTHER INFORMATION CONTACT: Narayan Nair, MD, MPH, Executive 
Secretary, Advisory Commission on Childhood Vaccines, Health Resources 
and Services Administration, Department of Health and Human Services, 
Room 08N146B, 5600 Fishers Lane, Rockville, MD 20857; phone: (301) 443-
6593; fax: (301) 443-8196; email: nnair@hrsa.gov.

SUPPLEMENTARY INFORMATION:  The ACCV was established by section 2119 of 
the Public Health Service Act (the Act) (42 U.S.C. 300aa-19), as 
enacted by Public Law (Pub. L.) 99-660, and as subsequently amended, 
and advises the Secretary of Health and Human Services (the Secretary) 
on issues related to implementation of the National Vaccine Injury 
Compensation Program (VICP). Other activities of the ACCV include: 
Recommending changes in the Vaccine Injury Table at its own initiative 
or as the result of the filing of a petition; advising the Secretary in 
implementing section 2127 of the Act regarding the need for childhood 
vaccination products that result in fewer or no significant adverse 
reactions; surveying federal, state, and local programs and activities 
related to gathering information on injuries associated with the 
administration of childhood vaccines, including the adverse reaction 
reporting requirements of section 2125(b) of the Act; advising the 
Secretary on the methods of obtaining, compiling, publishing, and using 
credible data related to the frequency and severity of adverse 
reactions associated with childhood vaccines; consulting on the 
development or revision of Vaccine Information Statements; and 
recommending to the Director of the National Vaccine Program research 
related to vaccine injuries which should be conducted to carry out the 
VICP.
    The charter renewal for ACCV was approved on July 20, 2018, which 
will also stand as the filing date. Renewal of the ACCV charter gives 
authorization for the Commission to operate until July 20, 2020.
    A copy of the ACCV charter is available on the VICP website at: 
https://www.hrsa.gov/advisory-committees/vaccines/index.html. A copy of 
the charter also can be obtained by accessing the FACA database that is 
maintained by the Committee Management Secretariat under the General 
Services Administration. The website address for the FACA database is 
http://www.facadatabase.gov/.

Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-15994 Filed 7-25-18; 8:45 am]
 BILLING CODE 4165-15-P

35490 Federal Register / Vol. 83, No. 144 / Thursday, July 26, 2018 / Notices

The estimated burden for this the administration of childhood Emphasis Panel; NIAID Resource-Related
information collection has changed vaccines, including the adverse reaction Research Projects (R24).
since the previous OMB approval. The reporting requirements of section Date: August 23, 2018.
current burden is based on the number 2125(b) of the Act; advising the Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
of actual new notifications received Secretary on the methods of obtaining, applications.
including notifications that were compiling, publishing, and using Place: National Institutes of Health, 5601
counted previously under the OMB credible data related to the frequency Fishers Lane, Rockville, MD 20892
approval for the interim final rule and severity of adverse reactions (Telephone Conference Call).
entitled ‘‘Permanent Discontinuance or associated with childhood vaccines; Contact Person: Dharmendar Rathore,
Interruption in Manufacturing of Certain consulting on the development or Ph.D., Senior Scientific Review Officer,
Drug or Biological Products’’ (80 FR revision of Vaccine Information Scientific Review Program, Division of
38915, July 8, 2015) (OMB control Statements; and recommending to the Extramural Activities, Room 3G30, National
number 0910–0699). Director of the National Vaccine Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
Dated: July 16, 2018. Program research related to vaccine 240–669–5058, rathored@mail.nih.gov.
Leslie Kux,
injuries which should be conducted to
Name of Committee: National Institute of
carry out the VICP. Allergy and Infectious Diseases Special
Associate Commissioner for Policy.
The charter renewal for ACCV was Emphasis Panel; NIAID Clinical Trial
[FR Doc. 2018–15948 Filed 7–25–18; 8:45 am]
approved on July 20, 2018, which will Implementation Cooperative Agreement
BILLING CODE 4164–01–P
also stand as the filing date. Renewal of (U01).
the ACCV charter gives authorization for Date: August 24, 2018.
the Commission to operate until July 20, Time: 11:00 a.m. to 1:00 p.m.
DEPARTMENT OF HEALTH AND Agenda: To review and evaluate grant
2020.
HUMAN SERVICES applications.
A copy of the ACCV charter is
Place: National Institutes of Health, 5601
Charter Renewal for the Advisory available on the VICP website at: Fishers Lane, Rockville, MD 20892
Commission on Childhood Vaccines https://www.hrsa.gov/advisory- (Telephone Conference Call).
committees/vaccines/index.html. A Contact Person: Chelsea D. Boyd, Ph.D.,
AGENCY: Health Resources and Services copy of the charter also can be obtained Scientific Review Officer, Scientific Review
Administration (HRSA), Department of by accessing the FACA database that is Program, DEA/NIAID/NIH/DHHS, 5601
Health and Human Services (HHS). maintained by the Committee Fishers Lane, MSC 9823, Rockville, MD
ACTION: Notice of charter renewal. Management Secretariat under the 20852–9834, 240–669–2081, chelsea.boyd@
General Services Administration. The nih.gov.
SUMMARY: HHS is hereby giving notice website address for the FACA database (Catalogue of Federal Domestic Assistance
that the Advisory Commission on is http://www.facadatabase.gov/. Program Nos. 93.855, Allergy, Immunology,
Childhood Vaccines (ACCV) has been and Transplantation Research; 93.856,
rechartered. The effective date of the Amy P. McNulty, Microbiology and Infectious Diseases
renewed charter is July 20, 2018. Acting Director, Division of the Executive Research, National Institutes of Health, HHS)
FOR FURTHER INFORMATION CONTACT: Secretariat. Dated: July 20, 2018.
Narayan Nair, MD, MPH, Executive [FR Doc. 2018–15994 Filed 7–25–18; 8:45 am] Natasha M. Copeland,
Secretary, Advisory Commission on BILLING CODE 4165–15–P Program Analyst, Office of Federal Advisory
Childhood Vaccines, Health Resources Committee Policy.
and Services Administration, [FR Doc. 2018–15953 Filed 7–25–18; 8:45 am]
Department of Health and Human DEPARTMENT OF HEALTH AND BILLING CODE 4140–01–P
Services, Room 08N146B, 5600 Fishers HUMAN SERVICES
Lane, Rockville, MD 20857; phone:
National Institutes of Health
(301) 443–6593; fax: (301) 443–8196; DEPARTMENT OF HOUSING AND
email: nnair@hrsa.gov. National Institute of Allergy and URBAN DEVELOPMENT
SUPPLEMENTARY INFORMATION: The ACCV Infectious Diseases; Notice of Closed
was established by section 2119 of the Meetings [Docket No. FR–5976–N–07]
Public Health Service Act (the Act) (42
Pursuant to section 10(d) of the Housing Opportunity Through
U.S.C. 300aa–19), as enacted by Public
Federal Advisory Committee Act, as Modernization Act of 2016: Final
Law (Pub. L.) 99–660, and as
amended, notice is hereby given of the Implementation of Public Housing
subsequently amended, and advises the
following meetings. Income Limit
Secretary of Health and Human Services
(the Secretary) on issues related to The meetings will be closed to the AGENCY: Office of the Assistant
implementation of the National Vaccine public in accordance with the Secretary for Public and Indian
Injury Compensation Program (VICP). provisions set forth in sections Housing, HUD.
Other activities of the ACCV include: 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
ACTION: Notice.
Recommending changes in the Vaccine as amended. The grant applications and
Injury Table at its own initiative or as the discussions could disclose SUMMARY: The Housing Opportunity
the result of the filing of a petition; confidential trade secrets or commercial Through Modernization Act of 2016
advising the Secretary in implementing property such as patentable material, (HOTMA) was signed into law on July
sradovich on DSK3GMQ082PROD with NOTICES

section 2127 of the Act regarding the and personal information concerning 29, 2016. One of the statutory
need for childhood vaccination individuals associated with the grant amendments made by HOTMA adds an
products that result in fewer or no applications, the disclosure of which income limit to the Public Housing
significant adverse reactions; surveying would constitute a clearly unwarranted program. This notice informs the public
federal, state, and local programs and invasion of personal privacy. of how HUD is setting that income limit
activities related to gathering Name of Committee: National Institute of and makes the income limit effective,
information on injuries associated with Allergy and Infectious Diseases Special while providing information to public

VerDate Sep<11>2014 17:25 Jul 25, 2018 Jkt 244001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\26JYN1.SGM 26JYN1

Document Created: 2018-11-06 10:27:01
Document Modified: 2018-11-06 10:27:01

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of charter renewal.
Contact		Narayan Nair, MD, MPH, Executive Secretary, Advisory Commission on Childhood Vaccines, Health Resources and Services Administration, Department of Health and Human Services, Room 08N146B, 5600 Fishers Lane, Rockville, MD 20857; phone: (301) 443- 6593; fax: (301) 443-8196; email: [email protected]
FR Citation		83 FR 35490